company

IMMUNE AS

7540 KLÆBU

Return on Equity
2 183,33 %
Current Ratio
1,06
Debt-to-Equity Ratio
0,08
Key figures (NOK)2022
Revenue412 000
Net Income262 000
Total Assets256 000
Total Equity12 000
Income (NOK)2022
Revenue412 000
Expenditure75 000
Operating Profit336 000
Financial Income0
Financial Costs0
Financial Balance0
Earnings Before Tax336 000
Tax74 000
Net Income262 000
Balance (NOK)2022
Total Fixed Assets0
Total Current Assets256 000
Total Assets256 000
Total Retained Equity−18 000
Total Equity12 000
Total Long-Term Debt1 000
Total Current Debt242 000
Total Equity and Debt256 000
Cash flow (NOK)2022
Sales Income412 000
Other Income0
Revenue412 000
Cost of Goods Sold4 000
Salary Costs0
Depreciation0
Impairment0
Expenditure75 000
Operating Profit336 000
Financial Income0
Financial Costs0
Financial Balance0
Dividends0
Net Income262 000
Balance details (NOK)2022
Goodwill0
Total Intangible Assets0
Real Eastate0
Machinery and Plant Facilities0
Fixtures0
Total Tangible Assets0
Total Fiancial Fixed Assets0
Total Fixed Assets0
Stock0
Total Investments0
Cash, Bank124 000
Total Current Assets256 000
Total Assets256 000
Total Equity12 000
Short-Term Group Debt0
Total Long-Term Debt1 000
Creditors0
Unpaid Taxes0
Dividends0
Other Current Debt168 000
Total Current Debt242 000
Total Equity and Debt256 000
Financial indicators2022
Return on Equity2 183,33 %
Debt-to-Equity Ratio0,08
Operating Profit Margin81,55 %
Current Ratio1,06
Quick Ratio1,06
Equity Ratio0,05
Gross Profit Margin99,03 %
RotateRotate your device to see the full table
HomeIndustriesNew CompaniesAbout
🇳🇴Norsk🇬🇧English